NextCure, Inc. — Director's Dealing 2020

Feb 21, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NextCure, Inc. (NXTC)
CIK: 0001661059
Period of Report: 2019-11-27

Reporting Person: Liu Linda (SVP, Research)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-27	Common Stock	M	34489	$.48	Acquired	34489	Direct
2019-11-27	Common Stock	M	20745	$1.21	Acquired	55234	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-27	Employee Stock Option (Right to Buy)	$.48	M	34489	Disposed	2026-09-01	Common Stock (34489)	Direct
2019-11-27	Employee Stock Option (Right to Buy)	$1.21	M	20745	Disposed	2027-03-15	Common Stock (20745)	Direct

Footnotes

F1: One fourth of the option vested on September 1, 2017. The remainder vests in 36 monthly installments beginning on October 1, 2017.

F2: One fourth of the option vested on March 15, 2018. The remainder vests in 36 monthly installments beginning on April 15, 2018.